MBio Diagnostics, Inc. Announces Additional $6 Million in Series B Funding
The funding supports the refinement of the MBio platform and improvements in manufacturing as the company scales-up to support its commercialization partners. The MBio platform brings remarkable simplicity of use and speed to a broad range of test modalities, from protein arrays and nucleic acid detection to cellular analysis.
from Biotech News
0 Comments